View all newsletters
Receive our newsletter - data, insights and analysis delivered to you


Blow, Fill and Seal Technology, Effervescent Tablets and Liquid Stick-Packs

ZI Longpre,
10 Rue Andre Durouchez,
80052 Amiens,

Unither is an independent pharmaceutical company specialising in the development and contract manufacture of the pharmaceutical formulations that patients and prescribers prefer :

  • Sterile unit-dose vials (Blow, Fill and Seal (BFS) technology)
  • Effervescent tablets
  • Liquid stick-packs

Unither undergoes regular inspections by national and international health authorities. It is compliant with European cGMP guidelines and has achieved ISO:13485 certification. We export to over 15 countries and attach great importance to the quality of our customer service.


As Europe’s leading manufacturer of sterile single-dose units, Unither has over 60 different moulds (from 0.25ml to 500ml) and can produce up to 1.5 billion units per year.


We can supply effervescent tablets packaged in tubes or in blister packs.

Our sterile unit-dose vials are easy to use, preservative free and easy to carry. They are one of the most accurate ways to ensure that you deliver the right dose every time.
Unither's effervescent tablets are easy to take and rapid-action.
Liquid stick-packs are easy to carry and use. The stick provides a barrier effect.
As part of an industrial group, Unither can provide its clients with full-service project development - from formulation to industrial manufacture.

As Europe’s joint leader in the manufacturing of effervescent tablets, Unither is increasing its production capacity to meet rising market needs.


The stick-pack presentation is an attractive alternative to liquid sachet or to any currently bottled product in this emerging market.

Unither has invested in a high-performance, flexible production tool located on a site with in-depth experience of liquid and paste formulations.


Located in Bordeaux within an innovation and healthcare cluster, Unither Développement possesses acknowledged expertise in the formulation and analytical development, as well as the production and packaging, of low scale batches.


  • Strategic outsourcing: our industrial specialisation in niche markets makes us a reliable partner for mid to long-term product subcontracts
  • New product development and manufacture: the development of a new form of an existing product can be a good way to boost a client’s product range
  • Turnkey licensing solutions: we develop innovative products – our clients have the commercial skills and resources to market them successfully under their own brand

Unither to Exhibit at ICSE/CPhI

Unither will be attending the CPhI/ICSE fair that will take place from 13-15 October in Madrid, Spain. Those interested in learning more about Unither services can meet us at booth 8E72, or contact us directly to pre-arrange a meeting. Unither is an independent pharmaceutical company sp

5 October 2009

Change of Shareholder

Unither has recently modified its equity: ING Parcom has replaced Société Générale Capital Europe (SGCE) as main shareholder. ING Parcom is a private equity company like SGCE. This move will enable Unither to pursue its development through organic growth or acquisiti

5 December 2006

Unither Pharmaceuticals

ZI Longpre
10 Rue Andre Durouchez
80052 Amiens

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology